Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-07-038963
Filing Date
2007-06-26
Accepted
2007-06-26 19:32:37
Documents
2
Period of Report
2007-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4178
2 POA DOCUMENT poa.txt EX-24.4_193693 3034
  Complete submission text file 0001209191-07-038963.txt   9029
Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130 (858) 436-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address 858-436-8600
Turner Heather D (Reporting) CIK: 0001403571 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 07942231